← Leaderboards
Christina M O'Grady
Tulane University Of Louisiana
$241,054
Attributed
$241,054
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $125K · FY2013–23$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$241,054 · 2
By mechanism
P20$124,950 · 1
F31$116,104 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Jennifer Erin Cameron$1,314,289
- William Russell Robinson$1,363,700
Others in their field
Top investigators on “S Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
S LymphomaTumor Suppressor ProteinsMalignant NeoplasmsPathway InteractionsHuman Herpesvirus 4TumorigenesisGene ExpressionMediatingViral ProteinsGenetic AnalysisGenesAids Malignancy ConsortiumAcquired Immunodeficiency SyndromeCommunity Clinical Oncology ProgramGeneticGenomeBiopsyEpstein-Barr Virus InfectionsEbv-Associated MalignancyCancer Specimen ResourceCarcinogenesisExpectationFusion GeneGene Expression Profile
Grant awards (4)
Divergent roles of nonsense-mediated RNA decay in oncovirus latency and reactivation$124,950
P20 · FY2023 · GM · contact PI
EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma$35,038
F31 · FY2015 · CA · contact PI
EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma$40,755
F31 · FY2014 · CA · contact PI
EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma$40,311
F31 · FY2013 · CA · contact PI